Proteomics analysis of human umbilical vein endothelial cells treated with resveratrol

Amino Acids

Volumn 43, Issue 4, 2012, Pages 1671-1678

  Shao, Bin ^a   Tang, Mei ^a   Li, Ziqiang ^a   Zhou, Rui ^a   Deng, Yaqi ^a   Nie, Chunlai ^a   Yuan, Zhu ^a   Zhou, Liangxue ^a   Tang, Minghai ^a   Tong, Aiping ^a   Wei, Yuquan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

2 DE; HUVECs; Proteomics; Resveratrol

Indexed keywords

1,2 DIHYDRO 3 KETO 5 METHYLTHIOPENTENE DIOXYGENASE; ACETYL NITIATION FACTOR 5A; BARRIER TO AUTOINTEGRATION FACTOR; COFILIN 1; DIOXYGENASE; ELONGATION FACTOR 2; HEAT SHOCK PROTEIN 27; INITIATION FACTOR 5A; NICOTINATE NUCLEOTIDE PYROPHOSPHORYLASE; NUCLEOTIDE PYROPHOSPHATASE; PHOSPHO HEAT SHOCK PROTEIN 27; PHOSPHO STATHMIN; PHOSPHORYLASE; RESVERATROL; STATHMIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMAGE ANALYSIS; IMMUNOBLOTTING; MASS SPECTROMETRY; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

ACYLATION; AMINO ACID SEQUENCE; ANTIOXIDANTS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; PROTEOMICS; STILBENES; TANDEM MASS SPECTROMETRY;

EUKARYOTA;

EID: 84867577605     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-012-1248-4     Document Type: Article

References (50)

1. Aging Statistics (2010) US Department of Health and Human Services. http://www.aoa.gov/aoaroot/aging- statistics/index.aspx
2. Barger JL, Kayo T, Vann JM, Arias EB, Wang J, Hacker TA et al (2008) Alow dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One 3(6):e2264
3. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra Aet al (2006) Resveratrol improves health and survival of mice on Ahigh-calorie diet. Nature 444(7117):337-342
4. Beher D, Wu J, Cumine S, Kim KW, Lu SC et al (2009) Resveratrol is not Adirect activator of SIRT1 enzyme activity. Chem Biol Drug Des 74(6):619-624
5. Bertoni AG, Goff DC Jr, D'Agostino RB Jr, Liu K, Hundley WG, Lima JA et al (2006) Diabetic cardiomyopathy and subclinical cardiovascular disease: the multi-ethnic study of atherosclerosis (MESA). Diabetes Care 29(3):588-594
6. Borradaile NM, Pickering JG (2009a) NAD(+), sirtuins, and cardiovascular disease. Curr Pharm Des 15(1):110-117
7. Borradaile NM, Pickering JG (2009b) Nicotinamide phosphoribosyltransferase imparts human endothelial cells with extended replicative lifespan and enhanced angiogenic capacity in Ahigh glucose environment. Aging Cell 8(2):100-112
8. Bradley CM, Ronning DR, Ghirlando R, Craigie R, Dyda F (2005) Structural basis for DNA bridging by barrier-to-Autointegration factor. Nat Struct Mol Biol 12(10):935-936
9. Braidy N, Guillemin GJ, Mansour H, Chan-Ling T, Poljak A, Grant R (2011) Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats. PLoS One 6(4):e19194
10. Buryanovskyy L, Fu Y, Boyd M, Ma Y, Hsieh TC et al (2004) Crystal structure of quinone reductase 2 in complex with resveratrol. Biochemistry 43(36):11417-11426
11. Capanni C, Cenni V, Haraguchi T, Squarzoni S, Schüchner S, Ogris E et al (2010) Lamin Aprecursor induces barrier-to-Autointegration factor nuclear localization. Cell Cycle 9(13):2600-2610
12. Chen D, Guarente L (2007) SIR2: Apotential target for calorie restriction mimetics. Trends Mol Med 13(2):64-71
13. Csiszar A, Labinskyy N, Pinto JT, Ballabh P, Zhang H, Losonczy G et al (2009) Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 297(1):H13-H20
14. Curmi PA, Gavet O, Charbaut E, Ozon S, Lachkar-Colmerauer S, Manceau V et al (1999) Stathmin and its phosphoprotein family: general properties, biochemical and functional interaction with tubulin. Cell Struct Funct 24(5):345-357
15. de Figueiredo LF, Gossmann TI, Ziegler M, Schuster S (2011) Pathway analysis of NAD+ metabolism. Biochem J 439(2):341-348
16. Dolinsky VW, Dyck JR (2011) Calorie restriction and resveratrol in cardiovascular health and disease. Biochim Biophys Acta 1812(11):1477-1489
17. Doshi BM, Hightower LE, Lee J (2010) HSPB1, actin filament dynamics, and aging cells. Ann N Y Acad Sci 1197:76-84
18. Ferns G, Shams S, Shafi S (2006) Heat shock protein 27: its potential role in vascular disease. Int J Exp Pathol 87(4):253-274
19. Gotoh I, Uekita T, Seiki M (2007) Regulated nucleo-cytoplasmic shuttling of human aci-reductone dioxygenase (hADI1) and its potential role in mRNA processing. Genes Cells 12(1):105-117
20. Harikumar KB, Aggarwal BB (2008) Resveratrol: Amultitargeted agent for age-Associated chronic diseases. Cell Cycle 7(8):1020-1035
21. Ishidoh K, Kamemura N, Imagawa T, Oda M, Sakurai J, Katunuma N (2010) Quinolinate phosphoribosyl transferase, Akey enzyme in de novo NAD(+) synthesis, suppresses spontaneous cell death by inhibiting overproduction of active-caspase-3. Biochim Biophys Acta 1803(5):527-533
22. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW et al (1997) Cancer chemopreventive activity of resveratrol, Anatural product derived from grapes. Science 275(5297):218-220
23. Jorgensen R, Merrill AR, Andersen GR (2006) The life and death of translation elongation factor 2. Biochem Soc Trans 34(Pt 1):1-6
24. Jungblut PR, Holzhütter HG, Apweiler R, Schlüter H (2008) The speciation of the proteome. Chem Cent J. 2:16
25. Kopp P (1998) Resveratrol, Aphytoestrogen found in red wine. Apossible explanation for the conundrum of the 'French paradox'? Eur J Endocrinol 138(6):619-620
26. Kostenko S, Moens U (2009) Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell Mol Life Sci 66(20):3289-3307
27. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F et al (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127(6):1109-1122
28. Lee SB, Park JH, Kaevel J, Sramkova M, Weigert R, Park MH (2009) The effect of hypusine modification on the intracellular localization of EIF5A. Biochem Biophys Res Commun 383(4):497-502
29. Lee MJ, Feliers D, Sataranatarajan K, Mariappan MM, Li M, Barnes JL et al (2010) Resveratrol ameliorates high glucose-induced protein synthesis in glomerular epithelial cells. Cell Signal 22(1):65-70
30. Lee SB, Park JH, Folk JE, Deck JA, Pegg AE, Sokabe M et al (2011) Inactivation of eukaryotic initiation factor 5A (eIF5A) by specific acetylation of its hypusine residue by spermidine/spermine acetyltransferase 1 (SSAT1). Biochem J 433(1):205-213
31. Lomenick B, Hao R, Jonai N, Chin RM, Aghajan M, Warburton S et al (2009) Target identification using drug affinity responsive target stability (DARTS). Proc Natl Acad Sci USA 106(51):21984-21989
32. McCullough BR, Grintsevich EE, Chen CK, Kang H, Hutchison AL, Henn Aet al (2011) Cofilin-linked changes in actin filament flexibility promote severing. Biophys J 101(1):151-159
33. Pacholec M, Bleasdale JE, Chrunyk B, Cunningham D, Flynn D, Garofalo RS et al (2010) SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 285(11):8340-8351
34. Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N et al (2008) Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8(2):157-168
35. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM et al (2011) Heart disease and stroke statistics2011 update: Areport from the American heart association. Circulation 123(4):e18-e209
36. Rouzer CA, Marnett LJ (2009) Cyclooxygenases: structural and functional insights. J Lipid Res 50(Suppl):S29-S34
37. Rubin CI, Atweh GF (2004) The role of stathmin in the regulation of the cell cycle. J Cell Biochem 93(2):242-250
38. Ryazanov AG, Shestakova EA, Natapov PG (1988) Phosphorylation of elongation factor 2 by EF-2 kinase affects rate of translation. Nature 334(6178):170-173
39. Shishodia S, Aggarwal BB (2006) Resveratrol: Apolyphenol for all seasons. In: Resveratrol in health and disease. Boca Raton CRC Press 1-16, pp
40. Smoliga JM, Baur JA, Hausenblas HA (2011) Resveratrol and healtha comprehensive review of human clinical trials. Mol Nutr Food Res 55(8):1129-1141
41. Tavernarakis N (2008) Ageing and the regulation of protein synthesis: Abalancing act? Trends Cell Biol 18(5):228-235
42. Tong A, Zhang H, Li Z, Gou L, Wang Z, Wei H et al (2008a) Proteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid. Cancer Chemother Pharmacol 61(5):791-802
43. Tong A, Wu L, Lin Q, Lau QC, Zhao X, Li J et al (2008b) Proteomic analysis of cellular protein alterations using Ahepatitis B virus-producing cellular model. Proteomics 8(10):2012-2023
44. Tseng SH, Lin SM, Chen JC, Su YH, Huang HY, Chen CK et al (2004) Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res 10(6):2190-2202
45. Ungvari Z, Orosz Z, Labinskyy N, Rivera A, Xiangmin Z et al (2007) Increased mitochondrial H2O2 production promotes endothelial NF-kappaB activation in aged rat arteries. Am J Physiol Heart Circ Physiol 293(1):H37-H47
46. Ungvari Z, Labinskyy N, Mukhopadhyay P, Pinto JT, Bagi Z, Ballabh P et al (2009) Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol 297(5):H1876-H1881
47. Van Maele B, Busschots K, Vandekerckhove L, Christ F, Debyser Z (2006) Cellular co-factors of HIV-1 integration. Trends Biochem Sci 31(2):98-105
48. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL et al (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430(7000):686-689
49. Yamamoto H, Schoonjans K, Auwerx J (2007) Sirtuin functions in health and disease. Mol Endocrinol 21(8):1745-1755
50. Zhang J (2006) Resveratrol inhibits insulin responses in ASirT1-independent pathway. Biochem J 397(3):519-527